CDC- BRFSS – ACBS 2019 Adult Prevalence Table 7

Table 7: Estimated percent using an inhaled corticosteroid in the past 3 months among adults1 with current2 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2019.
State/Territory Current
Sample
size±
% SE§ 95% CI
Arizona 244 27.3 4.7 (18.1 – 36.5)
California 261 32.8 3.8 (25.4 – 40.2)
Connecticut 272 38.5 4.8 (29.1 – 47.9)
Florida 473 24.5 3.8 (17.1 – 31.9)
Hawaii 193 23.6 3.7 (16.3 – 30.9)
Illinois 159 33.9 4.3 (25.5 – 42.3)
Indiana 227 33.9 3.9 (26.3 – 41.5)
Iowa 239 25.2 3.2 (18.9 – 31.5)
Kansas 279 28.5 4.1 (20.5 – 36.5)
Kentucky 290 23.5 3.6 (16.4 – 30.6)
Maine 486 28.6 3.4 (21.9 – 35.3)
Massachusetts 250 37.3 4.1 (29.3 – 45.3)
Michigan 492 30.8 2.8 (25.3 – 36.3)
Minnesota 475 26.5 2.4 (21.8 – 31.2)
Missouri 212 37.1 4.9 (27.5 – 46.7)
Montana 227 30.8 3.9 (23.2 – 38.4)
Nebraska 416 27.9 3.1 (21.8 – 34.0)
New Hampshire 288 34.2 3.7 (26.9 – 41.5)
New Mexico 181 24.3 4.2 (16.1 – 32.5)
Ohio 395 31.5 3.7 (24.2 – 38.8)
Oregon 269 32.7 3.3 (26.2 – 39.2)
Pennsylvania 221 31.8 3.9 (24.2 – 39.4)
Rhode Island 181 40.1 5.9 (28.5 – 51.7)
Texas 265 40.3 5.3 (29.9 – 50.7)
Utah 403 29.3 2.9 (23.6 – 35.0)
Vermont 239 39.7 5.1 (29.7 – 49.7)
Wisconsin 209 31.0 3.9 (23.4 – 38.6)
27 States / Area 7,846 32.1 1.1 (29.9 – 34.3)
Median 31.0
Range 23.5-40.3

1 Aged ≥ 18 years

2 “Yes” response to “Do you still have asthma?”

± Sample size for adults with current asthma, excludes “DK/Refused”

§ Standard error

Confidence interval

Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2019/pdf/sdq_report_acbs_19-508.pdf